1. Home
  2. ITOS vs FLIC Comparison

ITOS vs FLIC Comparison

Compare ITOS & FLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • FLIC
  • Stock Information
  • Founded
  • ITOS 2011
  • FLIC 1927
  • Country
  • ITOS United States
  • FLIC United States
  • Employees
  • ITOS N/A
  • FLIC N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • FLIC Major Banks
  • Sector
  • ITOS Health Care
  • FLIC Finance
  • Exchange
  • ITOS Nasdaq
  • FLIC Nasdaq
  • Market Cap
  • ITOS 272.5M
  • FLIC 275.5M
  • IPO Year
  • ITOS 2020
  • FLIC N/A
  • Fundamental
  • Price
  • ITOS $7.48
  • FLIC $13.28
  • Analyst Decision
  • ITOS Strong Buy
  • FLIC Hold
  • Analyst Count
  • ITOS 3
  • FLIC 1
  • Target Price
  • ITOS $21.33
  • FLIC $13.00
  • AVG Volume (30 Days)
  • ITOS 268.0K
  • FLIC 89.2K
  • Earning Date
  • ITOS 03-05-2025
  • FLIC 01-30-2025
  • Dividend Yield
  • ITOS N/A
  • FLIC 6.35%
  • EPS Growth
  • ITOS N/A
  • FLIC N/A
  • EPS
  • ITOS N/A
  • FLIC 0.75
  • Revenue
  • ITOS $35,000,000.00
  • FLIC $84,928,000.00
  • Revenue This Year
  • ITOS $271.18
  • FLIC N/A
  • Revenue Next Year
  • ITOS N/A
  • FLIC N/A
  • P/E Ratio
  • ITOS N/A
  • FLIC $17.64
  • Revenue Growth
  • ITOS N/A
  • FLIC N/A
  • 52 Week Low
  • ITOS $7.09
  • FLIC $9.30
  • 52 Week High
  • ITOS $18.75
  • FLIC $15.03
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 43.24
  • FLIC 53.95
  • Support Level
  • ITOS $7.30
  • FLIC $12.11
  • Resistance Level
  • ITOS $7.91
  • FLIC $13.21
  • Average True Range (ATR)
  • ITOS 0.32
  • FLIC 0.35
  • MACD
  • ITOS -0.02
  • FLIC 0.18
  • Stochastic Oscillator
  • ITOS 17.82
  • FLIC 66.02

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About FLIC First of Long Island Corporation (The)

First of Long Island Corp is a holding company that provides financial services. It offers services of saving accounts, current accounts, and capital gain accounts. The company also provides lending services, such as commercial and residential mortgage loans, industrial loans, small business credit scored loans, and other credit facilities. In addition, the company provides account reconciliation services, ATM Banking, bill payment, cash management services, mobile banking, online banking, and payroll services to privately owned businesses, professionals, consumers, and public bodies. Revenue earned by the company mainly consists of the interest on loans and investment securities, fees on deposit accounts, and income from investment management.

Share on Social Networks: